Description of the Service Provided. The Service offered by the Pharmacy will include all of the following: ● Distribution of a range of free injecting paraphernalia as deemed appropriate by We Are With You following national legislation and local policy. ● Provision of written information on harm reduction (for example on safer injecting or overdose prevention), plus ability to refer to We Are With You. ● Display the National Scheme logo. ● The Pharmacy will provide an introduction to the scheme and explain the rationale behind the Service to service users on first use. ● The service user will be provided with access to a user-friendly and confidential service from a quiet discreet area. ● The Pharmacy will encourage 100% returns and facilitate the safe disposal of used equipment. The Pharmacy should explore where needle syringe provision paraphernalia is being disposed. Non-returns should not impact on provision of equipment however strategies may be utilised to proactively encourage return. For example in the event where the service user frequently presents with no returns then the service user is not to be refused supply, but rather a one needle emergency pack is to be supplied. In recurrent exchanges where the service user returns the emergency pack, then the 10 pack can be dispensed. ● At least one sharps disposal device will be provided for each transaction. ● Information on the risks of unsafe disposal of injecting equipment. ● Consistent efforts to maximise return of used injecting equipment. ● Risk reduction advice and health promotion. This includes advice on a range of issues including the prevention of drug-related death, safer injecting technique, overdose prevention, blood-borne infections, contraception and safer sex, alcohol misuse, nutrition etc. ● Referral to other treatment services for effective health and social care as appropriate. ● Provision of information on the use of acidifiers encouraging the understanding of the health implications of overuse. ● Advice/interventions that prevent or curtail transition into injecting. These interventions should be targeted at current injectors and current smokers of substances than can be injected ● Advice/interventions on drug-related harm that does not involve injecting (e.g. harm related to smoking crack). ● The Pharmacy will record needle syringe provision activity and provide an explanation of the purpose of monitoring and what it is used for. ● The Pharmacy will use where available the online reporting service contracted by W...
Description of the Service Provided. The service offered by the Pharmacy will include all of the following: Distribution of a range of free sterile needles, syringes and equipment as deemed appropriate by purchaser following national legislation and local policy with written information on harm reduction (for example on safer injecting or overdose prevention), plus provision for referral to Lifeline (for example secondary care, vaccinations and drug treatment) using the attached referral form in the appendix. The pharmacy will stock equipment to account for different injecting practices or use of different substances. This may change due to national and local legislation. The pharmacy will provide an introduction to the scheme and explain the rationale behind the service-to-service users. The service user will be provided with access to a user-friendly and confidential service from a quiet discreet area. The pharmacy will encourage 100% returns and facilitate the safe disposal of used equipment. The pharmacy should explore where needle exchange paraphernalia is being disposed. However non- returns should not impact on provision of equipment. At least one sharps bin will be provided for every transaction. Each sharps bin will hold around 20 barrels. Information on the risks of unsafe disposal of injecting equipment. Consistent efforts to maximise return of used injecting equipment Risk reduction advice and health promotion. This includes advice on a range of issues including the prevention of drug-related death, safer injecting technique, overdose prevention, blood-borne infections, contraception and safer sex, alcohol misuse, nutrition etc Referral to other treatment services for effective health and social care as appropriate. Provision of information on the use of acidifiers encouraging the understanding of the health implications of overuse. Advice/interventions that prevent or curtail transition into injecting. These interventions should be targeted at current injectors and current smokers of substances than can be injected Advice/interventions on drug-related harm that does not involve injecting (e.g. harm related to smoking crack). The pharmacy will record needle exchange activity and provide an explanation of the purpose of monitoring and what it is used for. The pharmacy will use the online reporting service contracted by Lifeline to report the number of individuals seen, the total number of contacts, total number and stock given out by type. The pharma...
